Hematology NewsGenentech submits sNDA for venetoclax in untreated AMLJuly 12, 2018AMLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology TimesProtein could be target for MLL-rearranged AMLJuly 12, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesIdentifying patients with a high risk of AMLJuly 11, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsOral arsenic/ATRA is noninferior to IV form in APMLJuly 10, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsMutations may be detectable years before AML diagnosisJuly 10, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesA new use for ibrutinib?July 10, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology NewsVenetoclax with 5+2 chemo looks effective in older AML patientsJuly 9, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesCell therapy receives RMAT designationJuly 5, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesCHMP supports authorization of drug for AMLJuly 3, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesFDA lifts hold on trial of MYC inhibitorJuly 2, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesFDA grants priority review to drug for AMLJune 28, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesQuizartinib can prolong OS in rel/ref, FLT3-ITD AMLJune 18, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesIvosidenib active in R/R IDH1-mutated AML patientsJune 14, 2018Leukemia, Myelodysplasia, TransplantationAML
